"Proteolipids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Protein-lipid combinations abundant in brain tissue, but also present in a wide variety of animal and plant tissues. In contrast to lipoproteins, they are insoluble in water, but soluble in a chloroform-methanol mixture. The protein moiety has a high content of hydrophobic amino acids. The associated lipids consist of a mixture of GLYCEROPHOSPHATES; CEREBROSIDES; and SULFOGLYCOSPHINGOLIPIDS; while lipoproteins contain PHOSPHOLIPIDS; CHOLESTEROL; and TRIGLYCERIDES.
Descriptor ID |
D011510
|
MeSH Number(s) |
D10.570.780 D12.776.816
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Proteolipids".
Below are MeSH descriptors whose meaning is more specific than "Proteolipids".
This graph shows the total number of publications written about "Proteolipids" by people in this website by year, and whether "Proteolipids" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 4 | 1 | 5 |
1996 | 2 | 0 | 2 |
1997 | 3 | 0 | 3 |
1998 | 2 | 0 | 2 |
1999 | 1 | 1 | 2 |
2000 | 2 | 0 | 2 |
2001 | 1 | 0 | 1 |
2006 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Proteolipids" by people in Profiles.
-
Lee JA, Madrid RE, Sperle K, Ritterson CM, Hobson GM, Garbern J, Lupski JR, Inoue K. Spastic paraplegia type 2 associated with axonal neuropathy and apparent PLP1 position effect. Ann Neurol. 2006 Feb; 59(2):398-403.
-
White MK, Baireddy V, Strayer DS. Natural protection from apoptosis by surfactant protein A in type II pneumocytes. Exp Cell Res. 2001 Feb 15; 263(2):183-92.
-
Strayer DS, Korutla L. Activation of surfactant protein-B transcription: signaling through the SP-A receptor utilizing the PI3 kinase pathway. J Cell Physiol. 2000 Aug; 184(2):229-38.
-
White MK, Strayer DS. Surfactant protein A regulates pulmonary surfactant secretion via activation of phosphatidylinositol 3-kinase in type II alveolar cells. Exp Cell Res. 2000 Feb 25; 255(1):67-76.
-
Strayer DS, Hoek JB, Thomas AP, White MK. Cellular activation by Ca2+ release from stores in the endoplasmic reticulum but not by increased free Ca2+ in the cytosol. Biochem J. 1999 Nov 15; 344 Pt 1:39-46.
-
Korutla L, Strayer DS. SP-A as a cytokine: surfactant protein-A-regulated transcription of surfactant proteins and other genes. J Cell Physiol. 1999 Mar; 178(3):379-86.
-
Chen Q, Fisher AB, Strayer DS, Bates SR. Mechanism for secretagogue-induced surfactant protein A binding to lung epithelial cells. Am J Physiol. 1998 07; 275(1):L38-46.
-
Herting E, Strayer DS, Jarstrand C, Sun B, Robertson B. Lung function and bacterial proliferation in experimental neonatal pneumonia in ventilated rabbits exposed to monoclonal antibody to surfactant protein A. Lung. 1998; 176(2):123-31.
-
Cleary GM, Antunes MJ, Ciesielka DA, Higgins ST, Spitzer AR, Chander A. Exudative lung injury is associated with decreased levels of surfactant proteins in a rat model of meconium aspiration. Pediatrics. 1997 Dec; 100(6):998-1003.
-
Strayer DS, Schwarting R. Recognition of normal, neoplastic, and fetal airway epithelial cell membranes by two monoclonal antibodies. Hum Pathol. 1997 Jul; 28(7):840-6.